Mark E. Schmidt, MD
- 3Articles
- 7.5KReads
- 2000–2004Active
- 11Collaborators
About
Mark E. Schmidt, MD, has published research focused on the treatment of major depressive disorder (MDD), particularly examining the efficacy and safety of fluoxetine formulations during continuation therapy. His work includes studies on long-term treatment outcomes for depression with associated anxiety and patient compliance with a new enteric-coated weekly fluoxetine formulation. Schmidt has collaborated frequently with authors such as James M. Robinson and Maurizio Fava.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
